Eton Pharmaceuticals (ETON) Competitors $10.02 -0.44 (-4.21%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ETON vs. LXRX, SBBP, ASMB, GLYC, SLGL, APLT, PAHC, IMTX, COLL, and AVBPShould you be buying Eton Pharmaceuticals stock or one of its competitors? The main competitors of Eton Pharmaceuticals include Lexicon Pharmaceuticals (LXRX), Strongbridge Biopharma (SBBP), Assembly Biosciences (ASMB), GlycoMimetics (GLYC), Sol-Gel Technologies (SLGL), Applied Therapeutics (APLT), Phibro Animal Health (PAHC), Immatics (IMTX), Collegium Pharmaceutical (COLL), and ArriVent BioPharma (AVBP). These companies are all part of the "medical" sector. Eton Pharmaceuticals vs. Lexicon Pharmaceuticals Strongbridge Biopharma Assembly Biosciences GlycoMimetics Sol-Gel Technologies Applied Therapeutics Phibro Animal Health Immatics Collegium Pharmaceutical ArriVent BioPharma Lexicon Pharmaceuticals (NASDAQ:LXRX) and Eton Pharmaceuticals (NASDAQ:ETON) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking, media sentiment and valuation. Does the MarketBeat Community believe in LXRX or ETON? Lexicon Pharmaceuticals received 391 more outperform votes than Eton Pharmaceuticals when rated by MarketBeat users. Likewise, 64.86% of users gave Lexicon Pharmaceuticals an outperform vote while only 63.57% of users gave Eton Pharmaceuticals an outperform vote. CompanyUnderperformOutperformLexicon PharmaceuticalsOutperform Votes48064.86% Underperform Votes26035.14% Eton PharmaceuticalsOutperform Votes8963.57% Underperform Votes5136.43% Which has more volatility and risk, LXRX or ETON? Lexicon Pharmaceuticals has a beta of 1.24, suggesting that its stock price is 24% more volatile than the S&P 500. Comparatively, Eton Pharmaceuticals has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Is LXRX or ETON more profitable? Eton Pharmaceuticals has a net margin of -15.81% compared to Lexicon Pharmaceuticals' net margin of -4,109.41%. Eton Pharmaceuticals' return on equity of -36.29% beat Lexicon Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Lexicon Pharmaceuticals-4,109.41% -103.65% -63.20% Eton Pharmaceuticals -15.81%-36.29%-16.84% Do analysts prefer LXRX or ETON? Lexicon Pharmaceuticals currently has a consensus target price of $6.00, suggesting a potential upside of 515.26%. Eton Pharmaceuticals has a consensus target price of $13.00, suggesting a potential upside of 29.74%. Given Lexicon Pharmaceuticals' higher probable upside, equities analysts plainly believe Lexicon Pharmaceuticals is more favorable than Eton Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lexicon Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Eton Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation & earnings, LXRX or ETON? Eton Pharmaceuticals has higher revenue and earnings than Lexicon Pharmaceuticals. Eton Pharmaceuticals is trading at a lower price-to-earnings ratio than Lexicon Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLexicon Pharmaceuticals$3.64M65.95-$177.12M-$0.75-1.30Eton Pharmaceuticals$31.64M8.18-$940K-$0.22-45.55 Do institutionals and insiders hold more shares of LXRX or ETON? 74.7% of Lexicon Pharmaceuticals shares are held by institutional investors. Comparatively, 27.9% of Eton Pharmaceuticals shares are held by institutional investors. 6.8% of Lexicon Pharmaceuticals shares are held by company insiders. Comparatively, 14.9% of Eton Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer LXRX or ETON? In the previous week, Lexicon Pharmaceuticals had 1 more articles in the media than Eton Pharmaceuticals. MarketBeat recorded 21 mentions for Lexicon Pharmaceuticals and 20 mentions for Eton Pharmaceuticals. Eton Pharmaceuticals' average media sentiment score of 0.60 beat Lexicon Pharmaceuticals' score of 0.07 indicating that Eton Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lexicon Pharmaceuticals 2 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Eton Pharmaceuticals 4 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive SummaryEton Pharmaceuticals beats Lexicon Pharmaceuticals on 10 of the 18 factors compared between the two stocks. Ad Darwin2024's Must-Watch Stocks!Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ETON vs. The Competition Export to ExcelMetricEton PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$258.92M$6.39B$5.06B$8.67BDividend YieldN/A8.04%5.06%4.06%P/E Ratio-45.5510.1698.9217.12Price / Sales8.18266.571,205.7371.29Price / Cash3,316.8553.4940.6936.36Price / Book16.169.306.325.87Net Income-$940,000.00$154.14M$119.47M$225.66M7 Day Performance14.12%-9.49%-5.11%-1.34%1 Month Performance21.45%-7.23%-3.21%1.00%1 Year Performance183.85%30.70%32.41%25.27% Eton Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ETONEton Pharmaceuticals3.5803 of 5 stars$10.02-4.2%$13.00+29.7%+183.9%$258.88M$31.64M-45.5520Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading VolumeLXRXLexicon Pharmaceuticals2.0164 of 5 stars$1.06-3.2%N/A-8.0%$259.78M$1.20M-1.41285Earnings ReportAnalyst ForecastAnalyst RevisionSBBPStrongbridge BiopharmaN/A$2.00flatN/A+0.0%$135.66M$30.73M-2.6772Gap DownASMBAssembly Biosciences4.18 of 5 stars$17.48+4.7%N/A+92.1%$111.17M$7.16M0.00100Short Interest ↓Analyst RevisionGLYCGlycoMimetics3.8451 of 5 stars$0.40-1.5%N/A-69.0%$25.52M$10,000.00-0.6850Analyst ForecastShort Interest ↑SLGLSol-Gel Technologies3.6619 of 5 stars$0.52-1.4%N/A-65.7%$14.55M$6.56M-0.9750Short Interest ↓News CoverageGap UpAPLTApplied Therapeutics4.4519 of 5 stars$9.16+2.7%N/A+338.9%$1.07B$-333,000.00-5.6930Short Interest ↓News CoveragePAHCPhibro Animal Health4.3687 of 5 stars$24.78-1.9%N/A+132.3%$1.00B$1.02B57.631,940Analyst UpgradeIMTXImmatics2.3143 of 5 stars$8.37-2.3%N/A-3.9%$999.04M$58.44M-9.40260Short Interest ↓COLLCollegium Pharmaceutical4.1071 of 5 stars$30.67+1.6%N/A+17.8%$989.11M$599.25M13.22210AVBPArriVent BioPharma1.029 of 5 stars$28.38-10.9%N/AN/A$953.28MN/A0.0040Analyst ForecastNews Coverage Related Companies and Tools Related Companies LXRX Alternatives SBBP Alternatives ASMB Alternatives GLYC Alternatives SLGL Alternatives APLT Alternatives PAHC Alternatives IMTX Alternatives COLL Alternatives AVBP Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ETON) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eton Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eton Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
